Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Non-Current Assets (2018 - 2025)

Dna X filings provide 8 years of Other Non-Current Assets readings, the most recent being $274000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 28.65% to $274000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $274000.0, a 28.65% decrease, with the full-year FY2025 number at $274000.0, down 28.65% from a year prior.
  • Other Non-Current Assets hit $274000.0 in Q4 2025 for Dna X, down from $725000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.3 million in Q3 2022 to a low of $274000.0 in Q4 2025.
  • Median Other Non-Current Assets over the past 5 years was $3.0 million (2023), compared with a mean of $2.9 million.
  • Biggest five-year swings in Other Non-Current Assets: soared 644.54% in 2021 and later tumbled 87.0% in 2024.
  • Dna X's Other Non-Current Assets stood at $2.5 million in 2021, then increased by 17.75% to $3.0 million in 2022, then decreased by 0.64% to $3.0 million in 2023, then tumbled by 87.0% to $384000.0 in 2024, then fell by 28.65% to $274000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $274000.0 (Q4 2025), $725000.0 (Q3 2025), and $780000.0 (Q2 2025) per Business Quant data.